Following long-term outcomes in people with systemic lupus erythematosus
Follows adults with lupus over time to track disease activity and organ involvement.
Plain-language title generated from the registry record
Registry title: Long-Term Outcomes in SLE at Peking University People's Hospital
Key facts
- Where
- Beijing, ChinaSee the site
Where in China
- Department of Rheumatology and Immunology, Peking University People's HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peking University People's Hospital
- Trial code
- NCT07005479
- Record updated
- 5 June 2025
- Original description
This study aims to prospectively follow patients diagnosed with Systemic Lupus Erythematosus (SLE) at Peking University People's Hospital, assessing long-term outcomes such as disease activity, organ involvement, survival, and quality of life. Findings will support individualized patient management and contribute to understanding disease progression in the Chinese population.Read full original descriptionShow less
A Prospective Cohort Study on Long-Term Outcomes in Patients With Systemic Lupus Erythematosus at Peking University People's Hospital
This study aims to prospectively follow patients diagnosed with Systemic Lupus Erythematosus (SLE) at Peking University People's Hospital, assessing long-term outcomes such as disease activity, organ involvement, survival, and quality of life. Findings will support individualized patient management and contribute to understanding disease progression in the Chinese population.
Inclusion: All patients must meet at least one of the following classification criteria for Systemic Lupus Erythematosus (SLE):; The 1997 American College of Rheumatology (ACR) Revised Classification Criteria; The 2012 Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria; The 2019 EULAR/ACR Classification Criteria for SLE. All patients must be over the age of 18 and competent to provide written consent.
Exclusion: Patients less than 18 years of age and patients who are unable to consent are excluded from the study.